First Wave BioPharma Inc. (FWBI)
NASDAQ: FWBI
· Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM
First Wave BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -138.77K | -138.77K | -138.77K | 138.77K | 138.77K | 138.77K | 138.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 43.02K | 43.02K | 55.32K | 19.61K | 43.02K | 66.15K | 76.7K | 91.96K | 90.83K | 98.53K | 75.68K | 53.11K | 30.82K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -95.74K | -95.74K | -108.04K | 119.16K | 95.74K | 72.62K | 62.06K | -91.96K | -90.83K | -98.53K | -75.68K | -53.11K | -30.82K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.22M | -5.01M | -13.41M | -18.64M | -20.18M | -20.93M | -15.77M | -13.96M | -6.13M | -7.36M | -12.68M | -21.57M | -56.35M | -60.23M | -59.06M | -65.29M | -38.6M | -31.72M |
Interest Income | -681 | -681 | -453 | 452.00 | 681.00 | 886.00 | 2.53K | 6.99K | 9.43K | 10.15K | 8.41K | 3.73K | 1.06K | 139.00 | 403.00 | 403.00 | 403.00 | 403.00 |
Pretax Income | -5.39M | -7.82M | -15.85M | -18.72M | -20.26M | -21.02M | -15.79M | -15.68M | -7.85M | -9.07M | -14.63M | -21.82M | -56.61M | -60.48M | -58.54M | -64.77M | -39.68M | -35.1M |
Net Income | -20.93M | -28.74M | -21.91M | -9.92M | -10.78M | -6.16M | -15.81M | -17.4M | -9.58M | -10.8M | -16.58M | -22.06M | -56.86M | -60.72M | -58.54M | -64.77M | -39.68M | -35.1M |
Selling & General & Admin | 3.99M | 6.57M | 14.41M | 16.32M | 17.05M | 16.68M | 10.73M | 10.13M | 10.61M | 10.28M | 11.99M | 12.85M | 15.96M | 17.09M | 18.38M | 18.05M | 13.94M | 11.62M |
Research & Development | 2.21M | 2.42M | 2.97M | 2.3M | 3.1M | 4.24M | 5.03M | 3.83M | -4.48M | -2.92M | 691.26K | 6.37M | 38.04M | 40.78M | 38.32M | 47.24M | 24.66M | 20.1M |
Other Expenses | 1.15K | 1.15K | 495.00 | -1.15K | -1.15K | -3.76K | -4.22K | 2.83K | 2.83K | 5.45K | 6.56K | -4.28K | -4.85K | -3.95K | -3.95K | 330.00 | 898.00 | n/a |
Operating Expenses | 6.2M | 8.99M | 17.38M | 18.62M | 20.16M | 20.91M | 15.76M | 13.96M | 6.13M | 7.36M | 12.68M | 19.21M | 54M | 57.87M | 56.7M | 65.29M | 38.6M | 31.72M |
Interest Expense | -127.36K | -91.08K | -6.98K | 73.7K | 74.72K | 79.68K | 22.46K | 21.61K | 21.22K | 19.26K | 15.88K | 12.08K | 11.96K | 11.7K | 11.23K | 11.04K | 1.21M | 3.51M |
Selling & Marketing Expenses | 19.61K | 19.61K | 7.32K | -19.61K | -19.61K | -19.61K | -7.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.89M | 2.89M | 12.12M | 13.32M | 16.75M | 20.93M | 15.77M | 13.96M | 6.13M | 7.36M | 12.68M | 19.21M | 54M | 57.87M | 56.7M | 65.29M | 38.6M | 31.72M |
Income Tax Expense | 15.55M | 11.29M | -3.57M | -18.43M | -19.11M | -14.86M | 20.01K | 1.73M | 1.72M | 1.72M | 1.95M | 247.65K | 249.63K | 251.19K | 6.42K | 4.51K | 4.34K | 484.00 |
Shares Outstanding (Basic) | 4.77M | 4.77M | 3.43M | 4.55M | 2.29M | 1.76M | 1.56M | 378.3K | 113.55K | 114.03K | 49.75K | 228.77K | 103.84K | 74.02K | 61.53K | 44.49K | 37.2K | 26.36K |
Shares Outstanding (Diluted) | 4.77M | 4.77M | 3.43M | 4.55M | 2.29M | 14.51M | 1.56M | 378.3K | 113.55K | 114.03K | 49.75K | 232.25K | 103.84K | 74.02K | 61.53K | 44.49K | 37.2K | 26.36K |
EPS (Basic) | 2.18 | -1.47 | 1.93 | -3.96 | -12.45 | -45.48 | -84.45 | -196.24 | -167.96 | -183.17 | -280.68 | -129.62 | -832.18 | -1.03K | -1.19K | -2.51K | -2.22K | -2.32K |
EPS (Diluted) | 4.92 | 1.27 | 1.93 | -6.7 | -15.19 | -48.22 | -84.45 | -196.24 | -168.25 | -183.46 | -280.97 | -129.91 | -832.18 | -1.03K | -1.19K | -2.51K | -2.22K | -2.32K |
EBITDA | -4.69M | -7.47M | -15.86M | -18.62M | -20.15M | -20.9M | -15.74M | -15.63M | -7.8M | -9.02M | -14.58M | -19.29M | -53.95M | -57.7M | -55.63M | -64.21M | -37.31M | -30.42M |
EBIT | 16.75M | 16.75M | 7.53M | -13.32M | -16.75M | -20.94M | -15.77M | -15.66M | -7.83M | -9.05M | -14.61M | 519.02B | 518.98B | 518.98B | 518.98B | -64.75M | -38.47M | -31.58M |
Depreciation & Amortization | -26.93K | -26.93K | -14.64K | 19.61K | 26.93K | 34.25K | 30.03K | -1.67M | -1.67M | -1.67M | -1.91M | -76.42K | 51.87K | 177.5K | 542.25K | 548.18K | 549.99K | 557.44K |